Alivus Life Sciences Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Alivus Life Sciences (ALIVUS) Key Ratios
Alivus Life Sciences Share Price Analysis Local DB
Alivus Life Sciences share price is ₹1,250.60, day high (share price) is ₹1,295.80, day low (share price) is ₹1,208.10 and volume is 87,236. 52 Week high share price for Alivus Life Sciences is ₹1,493.80 on 31 Aug 2026 and 52 week low share price for Alivus Life Sciences is ₹819.00 on 22 Jan 2026. Price data as of: 23 Oct, 2026 3:31 PM.
According to latest price data (as of 23 Oct, 2026 3:31 PM) for Alivus Life Sciences share, 14 day period RSI (Relative Strength Index) is 31.9, 50 DMA (50 Displaced Moving Average) is 1,363.84 and 200 DMA (200 Displaced Moving Average) is 1,111.78.
Alivus Life Sciences (ALIVUS) Technical Analysis
Alivus Life Sciences Technical Data and Analysis available in multiple timeframes.
Alivus Life Sciences Oscillators Analysis
Alivus Life Sciences Price Action
Alivus Life Sciences Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 31.90 |
| Stoch %K (14, 3, 3) | 23.90 |
| CCI (20) | -178.28 |
| ADX (14) | 30.86 |
| Awesome Osc | -82.73 |
| Momentum (10) | -86.60 |
| MACD (12, 26, 9) | -25.36 |
| MACD Signal | -13.08 |
| Stoch RSI (14) | 5.64 |
| Williams %R (14) | -77.62 |
| Bull/Bear Power | -112.01 |
| Ultimate Osc | 46.54 |
| MFI (14) | 36.69 |
| ROC (21) | -8.99 |
| ROC (125) | 17.81 |
| ATR (14) | 49.22 |
Alivus Life Sciences Moving Averages
| Ichimoku Base | 1,327.05 | Below Base |
| VWMA (20) | 1,340.10 | Below VWMA |
| HMA (9) | 1,239.73 | Above HMA |
Alivus Life Sciences Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
WEAKNESSES
- Price is below the 50 DMA, suggesting weaker medium-term positioning.
- MACD is below the signal line and in negative territory, reflecting downward momentum.
- RSI at 31.9 indicates weakening momentum.
OPPORTUNITIES
- Price is near the lower Bollinger Band, which can reflect either oversold conditions or continued downward pressure.
THREATS
- No immediate technical risk signals are identified.
Alivus Life Sciences Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,322.40 | 1,327.85 | 1,279.26 | 1,301.20 |
| Resistance 2 | 1,301.20 | 1,303.93 | 1,275.84 | 1,286.95 |
| Resistance 1 | 1,285.10 | 1,290.55 | 1,272.42 | 1,278.15 |
| Pivot Point | 1,263.90 | 1,266.63 | 1,269.00 | 1,263.90 |
| Support 1 | 1,247.80 | 1,253.25 | 1,265.58 | 1,249.65 |
| Support 2 | 1,226.60 | 1,229.33 | 1,262.16 | 1,240.85 |
| Support 3 | 1,210.50 | 1,215.95 | 1,258.74 | 1,226.60 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Alivus Life Sciences - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 74.87% | 74.87% | 74.91% | 74.91% |
| FII | 5.54% | 5.29% | 5.09% | 6.84% |
| DII (Other) | 1.53% | 1.64% | 1.68% | 1.60% |
| Retail & Others | 12.41% | 12.56% | 12.88% | 12.78% |
| Mutual Funds | 5.65% | 5.63% | 5.44% | 3.87% |
Alivus Life Sciences - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2021 | 1,885.98 +21.73% | 470.94 +11.84% | 351.58 +12.29% |
| Mar 2020 | 1,549.30 +74.69% | 421.07 +84.44% | 313.10 +60.08% |
| Mar 2019 | 886.86 | 228.30 | 195.59 |
Alivus Life Sciences - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 01 Sep 2026 | ₹5 | View Details |
Announcement date
14 May 2026
Ex dividend date
01 Sep 2026
Record date
01 Sep 2026
Dividend type
Final
Amount
5.0
Dividend %
250.0
Details
Rs.5.0000 per share(250%)Final Dividend | |||
